Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease
BA Kingwell, MJ Chapman - Circulation, 2013 - Am Heart Assoc
The field of high-density lipoprotein (HDL) therapeutics is broadly aimed at combating the
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …
[引用][C] Future of high-density lipoprotein infusion therapies: Potential for clinical management of vascular disease
BA Kingwell, MJ Chapman - Circulation, 2013 - research.monash.edu
Future of high-density lipoprotein infusion therapies: Potential for clinical management of
vascular disease — Monash University Skip to main navigation Skip to search Skip to main …
vascular disease — Monash University Skip to main navigation Skip to search Skip to main …
[引用][C] Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease
BA Kingwell, MJ Chapman - Circulation, 2013 - pubmed.ncbi.nlm.nih.gov
Future of high-density lipoprotein infusion therapies: potential for clinical management of
vascular disease Future of high-density lipoprotein infusion therapies: potential for clinical …
vascular disease Future of high-density lipoprotein infusion therapies: potential for clinical …
[PDF][PDF] New Drugs and Technologies
BA Kingwell, MJ Chapman - Circulation, 2013 - Citeseer
The field of high-density lipoprotein (HDL) therapeutics is broadly aimed at combating the
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …
Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease.
BA Kingwell, MJ Chapman - Circulation, 2013 - europepmc.org
Future of high-density lipoprotein infusion therapies: potential for clinical management of
vascular disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
vascular disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
[引用][C] Future of High-Density Lipoprotein Infusion Therapies
BA Kingwell, MJ Chapman - Circulation, 2013 - cir.nii.ac.jp
Future of High-Density Lipoprotein Infusion Therapies | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
[PDF][PDF] New Drugs and Technologies
BA Kingwell, MJ Chapman - Circulation, 2013 - scholar.archive.org
The field of high-density lipoprotein (HDL) therapeutics is broadly aimed at combating the
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …
significant residual cardiovascular risk remaining after effective low-density lipoprotein (LDL) …
[引用][C] Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease
BA KINGWELL, MJ CHAPMAN - Circulation (New York, NY), 2013 - pascal-francis.inist.fr
Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of
Vascular Disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Vascular Disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …